Synonyms:
Status: Phase 2
Entry Type: Antibody
UNII: G86X5QQ7M5

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Epidermal growth factor receptor erbB1 inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference

Cross References

Resources Reference
ChEMBL CHEMBL4594472
FDA SRS G86X5QQ7M5